A Study of Subcutaneous Mircera, Versus no Erythropoiesis-Stimulating Agent (ESA) Therapy, in the Treatment of Anemia in Patients With Chronic Kidney Disease After Kidney Transplant
Clinical trial NCT00576602 · TERMINATED
Trial details
- NCT number
- NCT00576602
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2007-12-01
- Primary completion
- 2008-07-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.